December 9, 2011

Bernstein Liebhard LLP is investigating whether the Board of Directors of Blue Coat Systems, Inc. (“Blue Coat” or the “Company”) (NASDAQ: BCSI) breached its fiduciary duty to its shareholders in agreeing to sell Blue Coat to an investor group led by private equity investment firm Thoma Bravo, LLC.

Under the terms of the agreement, Blue Coat shareholders will receive $25.81 in cash for each share they own. The investigation is focused on the potential unfairness of the price to Blue Coat shareholders and the process by which the Blue Coat Board of Directors considered and approved the transaction.

If you are interested in discussing your rights as a Blue Coat shareholder and/or have information relating to the matter, please contact U. Seth Ottensoser at (877) 779-1414 or

Bernstein Liebhard has pursued hundreds of securities, consumer and shareholder rights cases and recovered over $3 billion for its clients. It has been named to The National Law Journal’s “Plaintiffs’ Hot List” in each of the last nine years.